Atlas5D, Inc.

Atlas5D, Inc. is a technology company dedicated to health and wellness assessment through its innovative Ambient Measurement System (AMS), which passively monitors and analyzes individual movements, particularly for elderly adults. Founded in 2011 and headquartered in Cambridge, US, Atlas5D, Inc. focuses on providing health monitoring solutions.

The company has successfully completed 3 deals, with its latest Series A funding round raising USD 3. 00 mn from GreyBird Ventures on February 1, 2016. The company's CEO is Timothy Chevalier. Atlas5D specializes in health and wellness assessment through an innovative product known as the Ambient Measurement System (AMS).

AMS is designed to passively monitor and analyze the motion of individuals, particularly targeting elderly adults who may live alone or reside in assisted living facilities. The system is capable of recognizing specific individuals, characterizing and quantifying their movements, and analyzing daily routines to predict potential health risks, such as falls. This technology provides critical insights to family members and caregivers, enabling them to make informed healthcare decisions. The product is easily set up in residential settings and operates without the need for user engagement or wearables, ensuring privacy and comfort for users.

Atlas5D's primary customer base includes individual consumers, assisted living facilities, and healthcare providers across various geographical markets, including the United States and Europe. Atlas5D generates revenue through a subscription-based model, where clients, including healthcare institutions and individual users, engage with the company for ongoing access to the AMS technology and its features. The transaction structure leverages partnerships with assisted living facilities and healthcare organizations, enabling these clients to integrate AMS into their health monitoring systems seamlessly. Clients receive regular updates and alerts regarding their loved ones' health status, contributing to the overall value provided by the service.

Specific pricing plans associated with AMS are designed to cater to both individual consumers and institutional clients, offering tailored packages to reflect the different needs and scales of use. The flagship product, AMS, remains central to the company’s revenue strategy, providing both clinical-grade measurements and reassurance for users concerned about health and safety. Atlas5D plans to utilize the USD 3. 00 mn raised in its Series A funding round to enhance product development and market expansion efforts.

The company is currently designing new features for the AMS system, aiming for a release targeted within the next 18 months. In addition, Atlas5D intends to enter new markets, particularly in Europe and Asia, by 2018, to broaden its user base and enhance its service offerings.